CYP1B1 has also been shown to metabolize endogenous compounds, such as arachidonic acid, producing hydroxyeicosatetraenoic acids, which may play a role in the development of inflammation, including IBD [31]. Here, CYP1B1 is linked to inflammatory bowel disease.